What is PFE's current stock price?

As of now, PFE is trading at $26.30, with a daily change of +1.54%.

What are PFE stock strengths?

PFE strengths include Pays a reliable dividend, Investors confidence is positive, Outperform the market, Earnings are forecast to grow, Trading below its fair value, Upgraded on attractively valued, .

What are the risks associated with PFE stock?

PFE Key risk is its Low Risk Level, .

What is PFE next earnings date?

PFE next earnings report is scheduled for Apr 29, 2025.

What is PFE's current stock rating?

PFE's current stock rating is Hold.

Should I buy PFE stock right now?

Based on the current rating of Hold, it is advisable to consider Hold as your next step with PFE stock.

Is PFE a Strong Buy right now?

PFE's current stock rating is Hold, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for PFE?

A 'Strong Buy' rating for PFE indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for PFE?

A 'Strong Sell' rating for PFE suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence PFE's stock rating?

PFE's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Pfizer (PFE) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

PFE

Pfizer

$26.30

+$0.40 | +1.54%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Open

$ 25.89

MKT CAP

$ 149.04B

High

$ 26.57

VOL

$ 54.06M

Low

$ 25.85

AVG VOL

$ 38.17M

Chart

26.72

25.64

29.16

26.08

1year

6month

3month

1month

PFE Latest Headlines +

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes. According to multiple media reports on Thursday ) has terminated the global development and commercialization of its hemophilia B gene therapy Beqvez.In April 2024 the FDA approved Beqvez for moderate to severe hemophilia B in adult patients who currently use factor IX prophylaxis therapy or have current or historical life-threatening hemorrhage or have repeatedserious spontaneousbleeding episodes and do not have neutralizing

Today

Activity

Potential

INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE). Berger Montague advises shareholders of Pfizer Inc. (Pfizer or the Company) (NYSE:) about an investigation into Pfizer'.s Board of Directors for potential breaches of fiduciary duties to Pfizer and its shareholders in connection with the Company'.s marketing and sale of Depo-Provera.Shareholders of Pfizermay learn more about this investigation by contacting Ber

Tue Feb 18, 2025

Activity

3 Things You Need to Know If You Buy Pfizer Today. Pfizer (NYSE: PFE) has been around for 175 years but the companys revenue soared to its highest ever only in more recent times. Thanks to its coronavirus treatment and vaccine the pharma giant reported more than $100 billion in revenue in 2022 at the peak of its pandemic succe

Tue Feb 18, 2025

Potential

Metastatic Castration-Resistant Prostate Cancer Market to Register Stupendous Growth During the Study Period (2020–2034) Owing to the Active Participation of Pharma Companies | DelveInsight. Metastatic Castration-Resistant Prostate Cancer Market to Register Stupendous Growth During the Study Period (2020–2034) Owing to the Active Participation of Pharma Companies |. DelveInsight The mCRPC market is expected to witness significant growth during the forecast period. Extensive market penetratio

Mon Feb 17, 2025

Activity

Potential

Is Pfizer Stock A Buy After Nabbing A Quarterly Beat On Its Covid Products?. Is Pfizer stock a buy after its Covid products drove a fourth-quarter sales beat? Is PFE stock now a buy or a sell?The post Is Pfizer Stock A Buy After Nabbing A Quarterly Beat On Its Covid Products? appeared first on Investor'.s Business Daily.

Fri Feb 14, 2025

Earnings

Potential

Explore our PFE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored PFE Stock Strategies
Effective Risk Management

FIND US ON

Receive our PFE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

PFE

Pfizer

$26.30

+$0.40 | +1.54%

Chart

26.72

25.64

29.16

26.08

1year

6month

3month

1month

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of PFE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our PFE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

PFE Stock trends

PFE Stock performance

PFE Stock analysis

PFE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

Sign up for free and

continue analysing PFE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

Sign up for free and

continue analysing PFE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

PFE Stock Analysis for the Last 90 Days

PFE Risk Level

PFE Analysts Opinion

PFE Street Consensus

PFE Performance Sentiment

Technical Price Levels

PFE Financial Health

PFE Fair Price vs Current Price

Explore our PFE Stock insights

Receive our PFE Daily Alerts

PFE Stock Analysis for the Last 90 Days

PFE Street Consensus

Technical Price Levels

PFE Fair Price vs Current Price

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of PFE. We're here to help you make informed investment decisions today.

Receive our PFE Daily Alerts